Is BB Biotech AG a good investment? BB Biotech AG (BION.SW) is currently trading at 52.10 CHF. Market analysts have a consensus price target of 69.00 CHF. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 3.49. This relatively low multiple may signal that BB Biotech AG is undervalued compared to historical market norms.
Earnings Schedule: BB Biotech AG is expected to release its next earnings report on Oct. 23, 2026. The market consensus estimate for Forward EPS is -0.66.
For income investors, BB Biotech AG pays a dividend yield of 4.43%. With a payout ratio of 9%, the dividend appears sustainable.
Yes, it pays an annual dividend of 2.25 CHF (4.43% yield).
BB Biotech AG is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Oct. 23, 2026. The company currently has a trailing EPS of 14.55.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
| Year | Total Dividends |
|---|---|
| ▸2027 |
2.01 CHF
|
| March 25, 2027 (estimated) | 2.0083 |
| ▸2026 |
2.25 CHF
|
| March 25, 2026 | 2.2500 |
| ▸2025 |
1.80 CHF
|
| March 25, 2025 | 1.8000 |
| ▸2024 |
2.00 CHF
|
| March 27, 2024 | 2.0000 |
| ▸2023 |
2.85 CHF
|
| March 29, 2023 | 2.8500 |
| ▸2022 |
3.85 CHF
|
| March 23, 2022 | 3.8500 |
| ▸2021 |
3.60 CHF
|
| March 24, 2021 | 3.6000 |
| ▸2020 |
3.40 CHF
|
| March 25, 2020 | 3.4000 |
| ▸2019 |
6.10 CHF
|
| May 17, 2019 | 3.0500 |
| March 27, 2019 | 3.0500 |
| ▸2018 |
3.30 CHF
|
| March 19, 2018 | 3.3000 |
| ▸2017 |
2.75 CHF
|
| March 22, 2017 | 2.7500 |
| ▸2016 |
17.40 CHF
|
| March 23, 2016 | 14.5000 |
| March 23, 2016 | 2.9000 |
| ▸2015 |
13.92 CHF
|
| March 24, 2015 | 2.3200 |
| March 24, 2015 | 11.6000 |
| ▸2014 |
8.40 CHF
|
| March 26, 2014 | 1.4000 |
| March 26, 2014 | 7.0000 |
| ▸2013 |
5.40 CHF
|
| March 25, 2013 | 4.5000 |
| March 25, 2013 | 0.9000 |
| ▸2011 |
3.84 CHF
|
| March 28, 2011 | 0.6400 |
| March 28, 2011 | 3.2000 |
| ▸2010 |
4.44 CHF
|
| April 7, 2010 | 3.7000 |
| April 7, 2010 | 0.7400 |
| ▸2009 |
2.16 CHF
|
| March 31, 2009 | 1.8000 |
| March 31, 2009 | 0.3600 |
| ▸2008 |
1.08 CHF
|
| April 7, 2008 | 0.1800 |
| April 7, 2008 | 0.9000 |
| ▸2007 |
2.40 CHF
|
| March 30, 2007 | 0.4000 |
| March 30, 2007 | 2.0000 |
| ▸2006 |
2.16 CHF
|
| April 26, 2006 | 1.8000 |
| April 26, 2006 | 0.3600 |
| ▸2005 |
2.88 CHF
|
| April 29, 2005 | 0.4800 |
| April 29, 2005 | 2.4000 |
| ▸2004 |
3.00 CHF
|
| April 21, 2004 | 2.5000 |
| April 21, 2004 | 0.5000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| BB Biotech AG | Mar 25, 2026 | Paid | 2.25 CHF |
| Split Date | Split Ratio to 1 |
|---|---|
| May 18, 2001 | 10.000000 |
| March 29, 2016 | 5.000000 |
Community Discussion